Germany’s BaFin looking into possible insider trading of CureVac shares
Reuters, 21 June 2021
BERLIN, June 21 (Reuters) – German financial watchdog BaFin is investigating possible insider trading of vaccine maker’s CureVac (5CV.DE) shares, which fell after the biotech firm announced its COVID-19 vaccine proved only 47% effective, Rheinische Post newspaper reported on Monday.
BaFin will investigate whether employees at CureVac or Bayer could have used their insider knowledge of the vaccine study results and sold shares in good time, the newspaper added. Continue reading “Article: Germany’s BaFin looking into possible insider trading of CureVac shares”
